When considering the interpretation of trial results, it is important to define the criteria that will justify investment in later stages of development. DaneStat will work with you to consider the literature available, the data you have from earlier trials and how the design of ongoing trials should help shape decision criteria. This information can be used to define trial result scenarios that would be strong enough to support product progression after accounting for the information available and the strength of evidence provided by the trial results.



DaneStat have experience in:

Reviewing the application of quantitative decision making on cross-functional governance committees

Applying Probability of Success to drug development programs

Authoring a probability of success guidance for a Biometric department.

Contributing to a book chapter on decision making